Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction
- PMID: 23525095
- PMCID: PMC4146523
- DOI: 10.1136/thoraxjnl-2012-202810
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction
Abstract
Background: Diagnosis of chronic obstructive pulmonary disease is based on detection of airflow obstruction on spirometry. There is no consensus regarding using a fixed threshold to define airflow obstruction versus using the lower limit of normal (LLN) adjusted for age. We compared the accuracy and discrimination of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommended fixed ratio of forced expiratory volume in the first second/forced vital capacity<0.70 with LLN in diagnosing smoking-related airflow obstruction using CT-defined emphysema and gas trapping as the disease gold standard.
Methods: Data from a large multicentre study (COPDGene), which included current and former smokers (age range 45-80 years) with and without airflow obstruction, were analysed. Concordance between spirometric thresholds was measured. The accuracy of the thresholds in diagnosing emphysema and gas trapping was assessed using quantitative CT as gold standard.
Results: 7743 subjects were included. There was very good agreement between the two spirometric cutoffs (κ=0.85; 95% CI 0.83 to 0.86, p<0.001). 7.3% were discordant. Subjects with airflow obstruction by fixed ratio only had a greater degree of emphysema (4.1% versus 1.2%, p<0.001) and gas trapping (19.8% vs 7.5%, p<0.001) than those positive by LLN only, and also smoking controls without airflow obstruction (4.1% vs 1.9% and 19.8% vs 10.9%, respectively, p<0.001). On follow-up, the fixed ratio only group had more exacerbations than smoking controls.
Conclusions: Compared with the fixed ratio, the use of LLN fails to identify a number of patients with significant pulmonary pathology and respiratory morbidity.
Conflict of interest statement
MTD received consultancy fees from Boehringer Ingelheim and GlaxoSmithKline. JDN received consultancy fees from VIDA Diagnostics. EAH is the founder of and owns stocks in VIDA Diagnostics. None of the other authors has any conflicts of interest to declare, pertinent to the subject of this manuscript.
Figures
Comment in
-
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.Thorax. 2014 Dec;69(12):1145-6. doi: 10.1136/thoraxjnl-2014-205960. Epub 2014 Sep 2. Thorax. 2014. PMID: 25182046 No abstract available.
-
Spirometric thresholds and biased interpretation of test results.Thorax. 2014 Dec;69(12):1146. doi: 10.1136/thoraxjnl-2014-206089. Epub 2014 Sep 2. Thorax. 2014. PMID: 25182048 No abstract available.
-
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: authors' response.Thorax. 2014 Dec;69(12):1147-8. doi: 10.1136/thoraxjnl-2014-206123. Epub 2014 Sep 9. Thorax. 2014. PMID: 25205585 No abstract available.
References
-
- Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709–721. - PubMed
-
- Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–1276. - PubMed
-
- Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest. 2006;130:200–206. - PubMed
-
- Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70% Chest. 2007;131:349–355. - PubMed
-
- Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical